The drug rizatriptan is often recommended for different types of migraines
Aleksandr Zubkov/Getty Images
A recent study has revealed that a commonly prescribed medication for migraines, rizatriptan, may not be as effective in alleviating vestibular migraines as previously thought. Vestibular migraines present with symptoms like vertigo, along with traditional migraine symptoms such as headaches and sensitivity to light. While rizatriptan is often suggested for these types of migraines, the study found that it did not significantly reduce vestibular symptoms.
According to Dr. Jeffrey Staab from the Mayo Clinic, research on vestibular migraine treatment has shown inconsistent results with various drugs. While newer medications like galcanezumab have shown promise in reducing the frequency of attacks, there has been a lack of randomized trials to determine the efficacy of migraine drugs in relieving vestibular symptoms during an episode.
In a study involving 134 adults with vestibular migraines, participants were instructed to take either 10 milligrams of rizatriptan or a placebo at the onset of vestibular symptoms. The results showed that rizatriptan was no more effective than a placebo in relieving symptoms one hour after intake, despite its reputation for fast action. However, after 24 hours, rizatriptan provided slightly better relief for some symptoms like sensitivity to motion, light, and sound, but not for vertigo.
Dr. Staab mentioned that rizatriptan, a type of drug known as triptans, is generally effective for treating migraine headaches but may not be as effective for vestibular symptoms. The study suggests that the brain pathways involved in vestibular migraines may not respond well to triptans, indicating the need for targeted treatment strategies specifically for vestibular migraines.
Dr. Peter Goadsby from King’s College London emphasized that vestibular migraines should not be considered a separate condition from other migraines but rather as a variation in migraine pathology that requires a distinct approach to treatment. He highlighted the importance of clinicians being aware of the limitations of certain medications in treating vestibular migraines and adjusting their treatment strategies accordingly.
